Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital

Scandinavian Journal of Rheumatology

Volumn 39, Issue 1, 2010, Pages 19-25

  De Thurah, A ^a   Norgaard M ^a   Johansen, M ^a   Stengaard Pedersen, K ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; HEMOGLOBIN; METHOTREXATE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; DENMARK; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRESCRIPTION; PRIORITY JOURNAL; PROBABILITY; PROFESSIONAL PRACTICE; RHEUMATOID ARTHRITIS; RHEUMATOLOGY; SYMPTOM; TREATMENT DURATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; COHORT STUDIES; CONFIDENCE INTERVALS; DENMARK; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION MEDIATORS; KAPLAN-MEIERS ESTIMATE; MALE; METHOTREXATE; MIDDLE AGED; ODDS RATIO; OUTPATIENT CLINICS, HOSPITAL; PROBABILITY; PROPORTIONAL HAZARDS MODELS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; RHEUMATOLOGY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 76649145630     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.3109/03009740903185987     Document Type: Article

References (32)

1. Sokka T, Envalds M, Pincus T. Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs. Mod Rheumatol 2008;/18:/228-39.
2. Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld FC, Dougados M, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies including Therapeutics (ESCISIT). Ann Rheum Dis 2006;/66:/34-45.
3. Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008;/59:/762-84.
4. Aletaha D, Smolen JS. The rheumatoid arthritis patient in the clinic: comparing more than 1,300 consecutive DMARD courses. Rheumatology (Oxford) 2002;/41:/1367-74.
5. Grijalva CG, Chung CP, Stein CM, Mitchel EF Jr, Griffin MR. Changing patterns of medication use in patients with rheumatoid arthritis in a medicaid population. Rheumatology (Oxford) 2008;/47:/1061-4.
6. Nikolaisen C, Kvien TK, Mikkelsen K, Kaufmann C, Rodevand E, Nossent JC. Contemporary use of diseasemodifying drugs in the management of patients with early rheumatoid arthritis in Norway. Scand J Rheumatol 2009 [Epub ahead of print]. DOI 10.1080/03009740802609566.
7. Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Ellingsen T, Andersen LS, et al. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebocontrolled study. Arthritis Rheum 2006;/54:/1401-9.
8. Lard LR, Visser H, Speyer I, vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;/111:/446-51.
9. van der Heide A, Jacobs JW, Bijlsma JW, Heurkens AH, van Booma-Frankfort C, van der Veen MJ, et al. The effectiveness of early treatment with 'second-line' antirheumatic drugs. A randomized, controlled trial. Ann Intern Med 1996;/124:/699-707.
10. Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Hansen I, Andersen LS, et al. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis 2008;/67:/ 815-22.
11. Sokka T, Kautiainen H, Toloza S, Makinen H, Verstappen SM, Lund Hetland M, et al. QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 2007;/66:/1491-6. (Pubitemid 350032658)
12. Kiely P, Williams R, Walsh D, Young A. for the Early Rheumatoid Arthritis Network (ERAN). Contemporary patterns of care and disease activity outcome in early rheumatoid arthritis: the ERAN cohort. Rheumatology (Oxford) 2009;48:57-60.
13. Anderson JJ, Wells G, Verhoeven AC, Felson DT. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum 2000;/43:/ 22-9.
14. Pedersen JK, Kjaer NK, Svendsen AJ, Horslev-Petersen K. Incidence of rheumatoid arthritis from 1995 to 2001: impact of ascertainment from multiple sources. Rheumatol Int 2008;/29:/ 411-5.
15. Andersen TF, Madsen M, Jorgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 1999;/ 46:/263-8.
16. Sorensen HT, Skriver MV, Friis S, McLaughlin JK, Blot WJ, Baron JA. Use of antibiotics and risk of breast cancer: a population-based case-control study. Br J Cancer 2005;/92:/594-6. (Pubitemid 40395544)
17. Sorensen HT, Friis S, Norgard B, Mellemkjaer L, Blot WJ, McLaughlin JK, et al. Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 2003;/88:/1687-92.
18. Introduction to drug utilization research. Oslo, Norway: World Health Organization, 2003. http://www.whocc.no/ atcddd/ (accessed 18 August 2009).
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;/40:/ 373-83.
20. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity: a critical review of available methods. J Clin Epidemiol 2003;/56:/221-9.
21. Singh JA, Holmgren AR, Noorbaloochi S. Accuracy of Veterans Administration databases for a diagnosis of rheumatoid arthritis. Arthritis Rheum 2004;/51:/952-7.
22. Christiansen JU, Maruard CD, Nielsen HC. LABKA. A realtime computer system for the clinical laboratory. Scand J Clin Lab Invest Suppl 1989;/194:/57-61.
23. The Danish National Board of Health, The Danish Institute for Health Technology Assessment. Rheumatoid arthritis- a medical technology assessment of diagnosis and treatment. Health Technology Assessment 2002:4, (summary in English). http://www.sst.dk/publ/Publ2003/SST-leddeg-AS5.pdf (accessed 18 August 2009).
24. Edwards CJ, Arden NK, Fisher D, Saperia JC, Reading I, Van Staa TP, et al. The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from the United Kingdom general practice research database. Rheumatology (Oxford) 2005;/44:/1394-8.
25. Aletaha D, Eberl G, Nell VP, Machold KP, Smolen JS. Attitudes to early rheumatoid arthritis: changing patterns. Results of a survey. Ann Rheum Dis 2004;/63:/1269-75.
26. Nikolaisen C, Figenschau Y, Nossent JC. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality. J Rheumatol 2008;/35:/380-6.
27. Gotzsche PC, Johansen HK. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Cochrane Database Syst Rev 2004;(3):/ D000189.
28. Schmajuk G, Schneeweiss S, Katz JN, Weinblatt ME, Setoguchi S, Avorn J, et al. Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum 2007;/57:/928-34.
29. Kremer JM, Alarcon GS, Lightfoot RW Jr, Willkens RF, Furst DE, Williams HJ, et al. Methotrexate for rheumatoid arthritis. Suggested guidelines for monitoring liver toxicity. American College of Rheumatology. Arthritis Rheum 1994;/37:/ 316-28.
30. Pedersen M, Klarlund M, Jacobsen S, Svendsen AJ, Frisch M. Validity of rheumatoid arthritis diagnoses in the Danish National Patient Registry. Eur J Epidemiol 2004;/19:/ 1097-103.
31. Singh JA, Holmgren AR, Noorbaloochi S. Accuracy of veterans administration databases for a diagnosis of rheumatoid arthritis. Arthritis Rheum 2004;(6):/952-7.
32. Yildirim K, Karatay S, Melikoglu MA, Gureser G, Ugur M, Senel K. Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis. Ann Clin Lab Sci 2004;/34:/423-6.